Regeneron Pharmaceuticals ceo salary
Leonard S. Schleifer, Board co-Chair, President and Chief Executive Officer of REGENERON PHARMACEUTICALS, INC. (REGN), received $8,184,338 ($8.2M) in total compensation for FY2023. Non-equity incentive compensation of $4,275,946 was the largest component. Figures come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 25 Apr 2024 (accession 0001308179-24-000577).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001308179-24-000577). These figures come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 25 Apr 2024 (accession 0001308179-24-000577).
| Component | Amount |
|---|---|
| Salary | $1,875,415 |
| Cash incentive | $4,275,946 |
| Other | $2,032,977 |
| Total | $8,184,338 |
FAQ
See also: REGN ticker page